Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Breyanzi
Pharma
FDA revisits CAR-T boxed warning on secondary cancers: Marks
“We are in the process ... of reevaluating the need for the current labeling on these products,” Peter Marks, M.D., Ph.D., said of the warnings.
Angus Liu
Nov 1, 2024 10:30am
BMS skates again on $6.4B Celgene shareholder lawsuit
Oct 1, 2024 10:45am
Bristol Myers secures another FDA go-ahead for Breyanzi
May 30, 2024 1:32pm
BMS' Breyanzi bags FDA nod to treat follicular lymphoma
May 16, 2024 10:56am
BMS signs $380M deal with cell therapy manufacturer Cellares
Apr 22, 2024 11:10am
Bristol Myers bags FDA nod to bring CAR-T to CLL
Mar 15, 2024 9:46am
